Keywords: Genzyme, Lumizyme, Pompe disease, FDA delay, Manufacturing faults

More bad news for Genzyme as US FDA delays Lumizyme application

Article | 17 November 2009

Print This

US biotechnology major Genzyme, which just a day earlier revealed that the US Food and Drug Administration found that vials ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in